XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue:      
Revenue $ 482,262 $ 350,867 $ 243,212
Cost of sales 172,059 117,808 85,450
Gross profit 310,203 233,059 157,762
Operating expenses:      
Research and development 70,115 44,033 32,015
Sales, general and administrative 374,080 300,013 229,271
Litigation-related expenses 22,287 23,943 11,123
Amortization of acquired intangible assets 14,284 10,115 5,348
Transaction-related expenses 2,113 120 6,365
Restructuring expenses 719 1,810 1,697
Total operating expenses 483,598 380,034 285,819
Operating loss (173,395) (146,975) (128,057)
Interest and other expense, net:      
Interest expense, net (16,641) (5,505) (7,108)
Loss on debt extinguishment, net     (7,434)
Other income (expense), net 3,121 471 (1,563)
Total interest and other expense, net (13,520) (5,034) (16,105)
Net loss before taxes (186,915) (152,009) (144,162)
Income tax benefit (277) (716) (1,130)
Net loss $ (186,638) $ (151,293) $ (143,032)
Net loss per share, basic $ (1.54) $ (1.46) $ (1.49)
Net loss per share, diluted $ (1.54) $ (1.46) $ (1.49)
Weighted average shares outstanding, basic 121,242 103,373 96,197
Weighted average shares outstanding, diluted 121,242 103,373 96,197
Products and Services      
Revenue:      
Revenue $ 482,262 $ 350,852 $ 242,258
International Supply Agreement      
Revenue:      
Revenue   $ 15 $ 954